<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03204526</url>
  </required_header>
  <id_info>
    <org_study_id>693382</org_study_id>
    <nct_id>NCT03204526</nct_id>
  </id_info>
  <brief_title>Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease</brief_title>
  <official_title>Safety and Feasibility of Using Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus to Improve Cognitive Performance in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <brief_summary>
    <textblock>
      Prospective trial of low frequency deep brain stimulation of the ventral subthalamic nucleus
      to improve cognitive performance in patients with advanced Parkinson's disease. All study
      participants have undergone DBS implantation surgery as part of their routine care for motor
      manifestations of Parkinson's disease. In this study, a temporary low frequency period of
      stimulation will be applied to determine its effects on cognition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">November 2019</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Beck's Depression Index</measure>
    <time_frame>After 72hours of test stimulation</time_frame>
    <description>Questionnaire with numerical score indicating level of depression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini Mental Status Exam</measure>
    <time_frame>After 72hours of test stimulation</time_frame>
    <description>Questionnaire with numerical score indicating level of cognitive impairment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety Scores</measure>
    <time_frame>After 72hours of test stimulation</time_frame>
    <description>Questionnaire with numerical score indicating level of anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>N-back</measure>
    <time_frame>After 72 hours of test stimulation</time_frame>
    <description>continuous performance task that measures working memory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop</measure>
    <time_frame>After 72 hours of test stimulation</time_frame>
    <description>task measures reaction time</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>low frequency stimulation (LFS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low-frequency deep brain stimulation of the subthalamic nucleus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>deep brain stimulation</intervention_name>
    <arm_group_label>low frequency stimulation (LFS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease, undergoing deep brain stimulation implantation as part of their
             routine management of motor symptoms.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California, Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 9, 2016</study_first_submitted>
  <study_first_submitted_qc>June 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

